These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 20723549)
1. Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice. Yang KJ; Noh JR; Kim YH; Gang GT; Hwang JH; Yang SJ; Yeom YI; Lee CH Life Sci; 2010 Sep; 87(13-14):405-10. PubMed ID: 20723549 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870 [TBL] [Abstract][Full Text] [Related]
3. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice. Roy S; Khanna V; Mittra S; Dhar A; Singh S; Mahajan DC; Priyadarsiny P; Davis JA; Sattigeri J; Saini KS; Bansal VS Life Sci; 2007 Jun; 81(1):72-9. PubMed ID: 17532347 [TBL] [Abstract][Full Text] [Related]
4. Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice. Mohapatra J; Sharma M; Singh S; Chatterjee A; Swain P; Balaraman R; Patel PR; Jain MR Pharmacology; 2009; 84(4):203-10. PubMed ID: 19738399 [TBL] [Abstract][Full Text] [Related]
5. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Lee MS; Kim CT; Kim Y Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166 [TBL] [Abstract][Full Text] [Related]
6. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice. Yamabe N; Kim HY; Kang KS; Zhao Q; Matsumoto K; Yokozawa T J Ethnopharmacol; 2010 Jun; 129(3):299-305. PubMed ID: 20363309 [TBL] [Abstract][Full Text] [Related]
7. Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adipose tissue in db/db mice. Sugimoto M; Arai H; Tamura Y; Murayama T; Khaengkhan P; Nishio T; Ono K; Ariyasu H; Akamizu T; Ueda Y; Kita T; Harada S; Kamei K; Yokode M Atherosclerosis; 2009 Jun; 204(2):388-94. PubMed ID: 19070857 [TBL] [Abstract][Full Text] [Related]
8. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice. Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863 [TBL] [Abstract][Full Text] [Related]
9. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice. Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207 [TBL] [Abstract][Full Text] [Related]
15. Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression. Bhavsar SK; Singh S; Giri S; Jain MR; Santani DD J Ethnopharmacol; 2009 Jul; 124(3):426-33. PubMed ID: 19505560 [TBL] [Abstract][Full Text] [Related]
16. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone. Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890 [TBL] [Abstract][Full Text] [Related]
17. Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice. Jatwa R; Parmar HS; Panda S; Kar A Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):177-80. PubMed ID: 17697037 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots. Kang JG; Park CY; Ihm SH; Yoo HJ; Park H; Rhee EJ; Won JC; Lee WY; Oh KW; Park SW; Kim SW Metabolism; 2010 Jan; 59(1):46-53. PubMed ID: 19716145 [TBL] [Abstract][Full Text] [Related]
19. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047 [TBL] [Abstract][Full Text] [Related]